GlassScriptPhysician profile
Janice L John
NPI 1477717189
$1,710.79
in general payments reported to CMS, 2019-2025
19 companies · $600 in 2025
The $600 reported for 2025 was more than what 94% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $528 · 2023: $295 · 2024: $288 · 2025: $600.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,183.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,182.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $613.73 | 2022-2025 | Hillrom - Vest System Model 105 Home Care |
| Takeda Pharmaceuticals U.S.A., INC. | $257.54 | 2022-2025 | Eohilia |
| Biogen, INC. | $222.77 | 2022-2025 | Spinraza, Tecfidera |
| Pharming Healthcare, INC. | $123.35 | 2023-2025 | Ruconest |
| Cranial Technologies, INC | $94.74 | 2022-2025 | Doc Band |
| Genzyme Corporation | $63.48 | 2023 | |
| Sobi, INC | $54.46 | 2022-2023 | |
| Ferring Pharmaceuticals INC. | $35.51 | 2025 | Rebyota |
| Soleno Therapeutics, INC. | $27.84 | 2025 | Vykat Xr |
| Ascendis Pharma Endocrinology INC | $26.67 | 2022 | |
| Alcresta Therapeutics, INC. | $25.47 | 2023 | Relizorb |
| Abbvie INC. | $24.93 | 2022 | |
| Harmony Biosciences LLC | $24.03 | 2025 | |
| Pfizer INC. | $23.84 | 2025 | |
| Grifols USA, LLC | $21.80 | 2023 | Xembify |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $21.75 | 2025 | |
| Azurity Pharmaceuticals, INC. | $20.00 | 2023 | Triptodur |
| Philips North America LLC | $15.01 | 2025 | Vest Therapy Und |
| Sarepta Therapeutics, INC. | $13.87 | 2024 | Elevidys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janice John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.